NTRK2 and amyotrophic lateral sclerosis: That can be the case of NMJs affected by amyotrophic lateral sclerosis, in which TrkB is impaired [23] and pharmacological activation of muscarinic receptors could transactivate TrkB to assure neurotransmission.